155 related articles for article (PubMed ID: 30309972)
1. Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review.
Law S; Daftary A; O'Donnell M; Padayatchi N; Calzavara L; Menzies D
Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30309972
[TBL] [Abstract][Full Text] [Related]
2. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
[TBL] [Abstract][Full Text] [Related]
3. 'They are inconveniencing us' - exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: perspectives from patients and clinicians in the Free State Province, South Africa.
Moodley N; Saimen A; Zakhura N; Motau D; Setswe G; Charalambous S; Chetty-Makkan CM
BMC Public Health; 2020 Apr; 20(1):454. PubMed ID: 32252703
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
[TBL] [Abstract][Full Text] [Related]
6. Why do patients with DR-TB do not complete their treatment? Findings of a qualitative study from Pakistan.
Abubakar M; Ullah M; Shaheen MA; Abdullah O
BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413123
[TBL] [Abstract][Full Text] [Related]
7. Loss to follow-up among patients diagnosed with spinal tuberculosis at a tertiary hospital in Western Cape Province, South Africa: A retrospective cohort study.
Mann TN; Davis JH; Dyers R
S Afr Med J; 2020 Mar; 110(4):284-290. PubMed ID: 32657739
[TBL] [Abstract][Full Text] [Related]
8. Impacts of social support on the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis.
Wen S; Yin J; Sun Q
BMJ Open; 2020 Oct; 10(10):e036985. PubMed ID: 33033087
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
Tupasi T; Garfin AM; Mangan JM; Orillaza-Chi R; Naval LC; Balane GI; Basilio R; Golubkov A; Joson ES; Lew WJ; Lofranco V; Mantala M; Pancho S; Sarol JN; Blumberg A; Burt D; Kurbatova EV
Int J Tuberc Lung Dis; 2017 Jan; 21(1):23-31. PubMed ID: 28157461
[TBL] [Abstract][Full Text] [Related]
10. Low BMI increases all-cause mortality rates in patients with drug-resistant TB.
Adamashvili N; Baliashvili D; Kuchukhidze G; Salindri AD; Kempker RR; Blumberg HM; Lomtadze N; Avaliani Z; Magee MJ
Int J Tuberc Lung Dis; 2022 Apr; 26(4):326-333. PubMed ID: 35351237
[TBL] [Abstract][Full Text] [Related]
11. 'I didn't know so many people cared about me': support for patients who interrupt drug-resistant TB treatment.
Snyman L; Venables E; Trivino Duran L; Mohr E; Azevedo VD; Harmans X; Isaakidis P
Int J Tuberc Lung Dis; 2018 Sep; 22(9):1023-1030. PubMed ID: 30092867
[TBL] [Abstract][Full Text] [Related]
12. Innovative approach to the design and evaluation of treatment adherence interventions for drug-resistant TB.
Alegria-Flores K; Weiner BJ; Wiesen CA; Lich KLH; Van Rie A; Paul JE; Tovar MA
Int J Tuberc Lung Dis; 2017 Nov; 21(11):1160-1166. PubMed ID: 29037297
[TBL] [Abstract][Full Text] [Related]
13. Loss to follow-up and opportunities for reengagement in HIV care in rural Mozambique: A prospective cohort study.
Fuente-Soro L; López-Varela E; Augusto O; Bernardo EL; Sacoor C; Nhacolo A; Ruiz-Castillo P; Alfredo C; Karajeanes E; Vaz P; Naniche D
Medicine (Baltimore); 2020 May; 99(20):e20236. PubMed ID: 32443358
[TBL] [Abstract][Full Text] [Related]
14. Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India.
Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas A; Kumar AM; Satyanarayana S; Parmar M; Moonan PK; Lo TQ
PLoS One; 2015; 10(8):e0135802. PubMed ID: 26301748
[TBL] [Abstract][Full Text] [Related]
15. Home based care to multi-drug resistant tuberculosis patients: A pilot study.
Vaghela JF; Kapoor SK; Kumar A; Dass RT; Khanna A; Bhatnagar AK
Indian J Tuberc; 2015 Apr; 62(2):91-6. PubMed ID: 26117478
[TBL] [Abstract][Full Text] [Related]
16. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB
BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829
[TBL] [Abstract][Full Text] [Related]
17. High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.
Hirasen K; Berhanu R; Evans D; Rosen S; Sanne I; Long L
PLoS One; 2018; 13(10):e0205463. PubMed ID: 30300403
[TBL] [Abstract][Full Text] [Related]
18. Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations.
Garcia-Prats AJ; Rose PC; Hesseling AC; Schaaf HS
Tuberculosis (Edinb); 2014 Mar; 94(2):93-104. PubMed ID: 24388605
[TBL] [Abstract][Full Text] [Related]
19. Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.
Toczek A; Cox H; du Cros P; Cooke G; Ford N
Int J Tuberc Lung Dis; 2013 Mar; 17(3):299-307. PubMed ID: 23211716
[TBL] [Abstract][Full Text] [Related]
20. Implementation fidelity of hospital based directly observed therapy for tuberculosis treatment in Bhutan: mixed-method study.
Dorji K; Lestari T; Jamtsho S; Mahendradhata Y
BMC Public Health; 2020 Apr; 20(1):533. PubMed ID: 32306977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
